Adaltis
Adaltis S.r.l. is a privately held Italian IVD manufacturer founded in 1987 that develops automated molecular diagnostics and microELISA instruments paired with proprietary reagent kits, serving clinical laboratories, hospitals, and blood banks globally through CE-IVD-marked products and a distributor network.
- Company typePrivate
- Founded1987
- HeadquartersMontecelio, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Adaltis does
Adaltis S.r.l. is a privately held Italian in-vitro diagnostics (IVD) manufacturer, founded in 1987 and headquartered in Guidonia di Montecelio near Rome, with a registered office in Milan. The company develops, manufactures, and markets automated clinical diagnostic analysers paired with proprietary reagent kits, serving clinical laboratories, hospitals, blood banks, and public health / research institutions across multiple international markets through a global distributor network and direct sales support.
The product portfolio is organised around two technology platforms. The Molecular Diagnostics platform comprises the MDXlab integrated nucleic-acid extraction and detection system, the AMPLilab real-time PCR system, the EXTRAlab NGS Prep extraction instrument, and the eLAB automated extractor, used with the MOLgen reagent line covering syndromic infectious disease panels, HIV, hepatitis, sexually transmitted infections, tuberculosis, herpes / ToRCH, tick-borne infections, and genetics. The MicroELISA immunoassay platform comprises the Personal LAB (2 microplate, dual chemiluminescence and colorimetric) and the NEXgen (7 microplate, open system) analysers, run with the EIAgen and CLIAgen reagent brands. The company also supplies Pchem clinical chemistry reagents and Blue Star TMB substrate, plus OEM / conjugates production services. Reagent kits are validated for compatibility with Bio-Rad CFX96, iQ5 iCycler, and DNA-Technology DT-96 real-time PCR systems.
Adaltis makes money by selling instruments (one-time hardware revenue), proprietary reagent kits (recurring consumable revenue with MOQs of 5 kits per code and a €225 handling fee on orders under €1,500), accessories and spare parts (aftermarket revenue), OEM / custom manufacturing services, and fee-based training delivered at the Adaltis Training Centre in Guidonia. Pricing is quote-based and not publicly disclosed; orders below €5,000 require full advance payment and products ship with a minimum 10-month shelf life. Products are CE-IVD marked under Directive 98/79/EC and Regulation (EU) 2017/746 (IVDR), and the quality system is certified to ISO 9001:2015 and ISO 13485:2016 by BSI. Recent product activity has centred on COVID-19 diagnostics (EIAgen SARS-CoV-2 ELISA in 2020 and MOLgen SARS-CoV-2 Omicron kit in 2021) and the 2025 conclusion of the MYTUS tuberculosis identification and drug-resistance project.
Adaltis firmographics
Firmographics- Name
- Adaltis
- Legal name
- Adaltis S.r.l.
- Website
- https://adaltis.net
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Adaltis S.r.l. is a privately held Italian IVD manufacturer founded in 1987 that develops automated molecular diagnostics and microELISA instruments paired with proprietary reagent kits, serving clinical laboratories, hospitals, and blood banks globally through CE-IVD-marked products and a distributor network.
- Ownership category
- akta.pro rank
Adaltis industry classification
Industry- Product category
- In-Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Adaltis is headquartered
LocationHeadquarters
- HQ city
- Montecelio
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
Adaltis business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- IVD Instruments Sales: Sale of automated clinical diagnostic analyzers including MDXlab, AMPLilab, EXTRAlab NGS Prep, eLAB, Personal LAB, and NEXgen systems. Instruments are sold directly and through distribution network.
- IVD Reagent Kits: Sale of molecular diagnostic reagent kits (MOLgen line) and microELISA reagents (EIAgen, CLIAgen lines) for use with company's and compatible instruments. Includes syndromic panels, infectious disease tests, and specialty assays.
- Accessories, Consumables & Spare Parts: Continuous aftermarket revenue from consumables (liquids, tubes, vials, cuvettes, disposable tips), accessories (computer accessories, technical documentations, software/firmware, instrument accessories, tools), and spare parts (electronic boards, mechanical parts, hydraulic parts, optical parts, maintenance kits, packaging).
- OEM Services: Custom OEM manufacturing services for conjugates production and other IVD components.
- Training Services: Fee-based training programs conducted at the Adaltis Training Centre in Guidonia, Italy for application and service training on instruments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | IVD Instruments - Automated analyzers and diagnostic platforms |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Adaltis product offering
Product offeringCore offering
Adaltis S.r.l. develops, manufactures, and markets in-vitro diagnostic (IVD) instruments and reagent kits for clinical laboratories, hospitals, blood banks, and research institutions. The portfolio combines Molecular Diagnostics instruments (MDXlab integrated platform, AMPLilab real-time PCR, EXTRAlab NGS Prep, eLAB automated extractor) with MOLgen RT-PCR and syndromic test kits, alongside MicroELISA immunoassay instruments (Personal LAB, NEXgen) paired with EIAgen and CLIAgen reagent lines, Pchem clinical chemistry reagents, Blue Star TMB substrate, OEM services, and consumables/spare parts.
Product overview
Adaltis is an international IVD company headquartered in Rome, Italy that develops, manufactures, and markets in-vitro diagnostic systems and reagents. The product portfolio operates across two main technology platforms: Molecular Diagnostics and MicroELISA Immunoassay. The Molecular Diagnostics platform consists of instruments (MDXlab, EXTRAlab NGS Prep, AMPLilab, eLAB) paired with MOLgen reagent kits for syndromic testing, infectious disease detection (HIV, hepatitis, TB, STIs, respiratory infections, tick-borne diseases, gastrointestinal infections), and genetic testing. The MicroELISA platform includes instruments (Personal LAB, NEXgen) used with EIAgen and CLIAgen reagent brands for immunoassay testing covering retrovirus, hepatitis, and syphilis. The company also offers Clinical Chemistry reagents (Pchem), TMB substrate solutions (Blue Star), conjugates production services, and OEM services. All products are supported by a comprehensive range of accessories, consumables, and spare parts.
Differentiator
Problem solved
Functional benefit
Brands
- MOLgen: Molecular diagnostic panels and reagent kits for nucleic acid extraction and RT-PCR of infectious diseases and genomics
- EIAgen
- CLIAgen
- Pchem
- MDXlab
- AMPLilab
- EXTRAlab
- Personal LAB
- NEXgen
- eLAB
- Blue Star
Products and services
- MDXlab Fully Integrated Nucleic Acid Extraction & Detection Platform offering nucleic acid extraction, PCR set-up, and PCR amplification & detection in a universal and compact format for clinical diagnostics.
- AMPLilab Fully-automated Molecular Diagnostics Real-time PCR System for nucleic acid amplification and detection of infectious agents.
- EXTRAlab NGS Prep Fully-automated Molecular Diagnostics Nucleic Acid Extraction instrument with preloaded protocols for automated extraction and PCR set-up, for NGS preparation workflows.
- eLAB Automated Nucleic Acid Extractor for molecular diagnostics sample preparation.
- Personal LAB Fully Automated 2 Microplate Analyser supporting both chemiluminescence (CLIA) and colorimetric (EIA) microELISA assays; can be connected to LIS through serial (RS-232) connection.
- NEXgen Fully Automated 7 Microplates Open System MicroELISA analyzer for high-throughput immunoassay processing with open system capability for programmable third-party assays.
- MOLgen Molecular Diagnostic Kits Proprietary molecular diagnostic reagent kits for nucleic acid extraction and RT-PCR of infectious diseases and genomics, available in universal format (compatible with most RT-PCR instruments) and strip format (compatible with AMPLilab, CFX96, iCycler). Includes syndromic panels for bacteria, viruses, fungi, and parasites detection in single tests.
- EIAgen MicroELISA Reagents Complete range of Microplate Assays for enzyme-linked immunosorbent assay (ELISA) testing, including tests for retrovirus, hepatitis, and syphilis detection.
- CLIAgen Chemiluminescence Reagents Chemiluminescence microELISA assays for high-sensitivity immunoassay detection, run on Personal LAB and NEXgen analyzers.
- Pchem Clinical Chemistry Reagents Clinical chemistry reagents for laboratory diagnostics including HbA1c and other chemistry tests.
- Blue Star TMB Solution TMB substrate solution for ELISA applications providing colorimetric detection for immunoassays.
- Accessories, Consumables & Spare Parts Comprehensive range of accessories, consumables, and spare parts including liquids, tubes, vials, cuvettes, disposable tips, computer accessories, technical documentations, software/firmware, instrument accessories, tools, electronic boards, mechanical parts, hydraulic parts, optical parts, maintenance kits, and packaging materials for Adaltis instruments.
- OEM Services Original Equipment Manufacturing (OEM) services for IVD products and components, including custom conjugates production and other IVD components.
- Conjugates Production Services Custom conjugates production activities for antibody and hybridoma development supporting IVD assay development.
- Training Services Fee-based application and service training programs conducted at the Adaltis Training Centre in Guidonia, Italy, covering instrument operation and maintenance.
Quantifiable outcome
- MDXlab platform integrates nucleic acid extraction, PCR setup, and PCR amplification/detection in a single compact platform
- +1 more outcomes
Companies that use Adaltis
Customer profileSegments3 records
Ideal customer profiles3 records
Adaltis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature8 records
Adaltis partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- ISE. Srl (Logotech Group)coreISE. Srl is part of the Logotech Group and serves as a group company partner for Adaltis. ISE. Srl focuses on Clinical Chemistry Analysers and Reagents for laboratories, complementing Adaltis's molecular diagnostics and microELISA offerings. The partnership provides comprehensive IVD solutions spanning molecular diagnostics, immunoassays, and clinical chemistry testing.
- Bio-Rad LaboratoriescoreAdaltis MOLgen reagent kits are validated and designed for use with Bio-Rad RT-PCR instruments including iQ iCycler, iQ5 iCycler, and CFX96 systems. This integration enables compatibility between Adaltis molecular diagnostic reagents and widely used Bio-Rad real-time PCR platforms.
- DNA-Technology (Russia)Adaltis MOLgen reagent kits are validated for use with DT-96 real-time PCR detection systems from DNA-Technology (Russia), enabling compatibility with this Eastern European diagnostic platform.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Adaltis competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Bio-Rad is a direct peer: Adaltis MOLgen kits are validated for Bio-Rad's CFX96 and iQ iCycler real-time PCR systems, and both sell molecular diagnostics reagents and instruments into clinical labs and blood banks globally.
- DiaSorin: Italian-headquartered DiaSorin is a direct peer competing in IVD immunoassays (CLIA and ELISA) and molecular diagnostics, with a similar reagent-plus-instrument model and global distribution, though at materially larger scale than Adaltis.
- ELITech Group: ELITech is a direct peer offering molecular diagnostics reagents and clinical chemistry instruments to mid-sized labs in Europe and emerging markets, overlapping with Adaltis on RT-PCR kits and microplate immunoassay analyzers.
- Meridian Bioscience: Meridian is a direct peer in IVD molecular diagnostics and immunoassays serving clinical labs with kits and life-science reagents; both target infectious disease detection workflows.
Broad incumbents
- Roche Diagnostics: Roche Diagnostics is a broad incumbent offering the cobas line of fully-integrated molecular diagnostics and immunoassay systems; competes with Adaltis across molecular and immunoassay categories but at vastly greater scale and with broader menus.
- Abbott Diagnostics: Abbott Diagnostics competes broadly with Adaltis through the m2000 and Alinity platforms for molecular diagnostics and ARCHITECT for immunoassays; serves the same clinical lab and hospital customer base.
- Hologic: Hologic's Panther and Aptima molecular systems compete with Adaltis in syndromic and infectious disease molecular diagnostics for clinical labs; operates as a broad incumbent with deeper US footprint.
Regional players
- A. Menarini Diagnostics: Italian peer providing clinical chemistry and immunoassay analyzers and reagents; overlaps with Adaltis on clinical chemistry and microELISA instruments but is more concentrated in European markets.
- Copan Diagnostics: Italian-based Copan is a peer in the molecular diagnostics sample-preparation workflow through automated specimen processing and nucleic acid extraction, complementing Adaltis's MDXlab and EXTRAlab offerings.
Emerging players
- Quotient Limited: Quotient is an emerging player in transfusion diagnostics and blood-bank serology, directly competing with Adaltis's CE-IVD blood-banking assays and immunoassay reagents targeting donor screening.
Market position
Strengths3 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Adaltis social profiles
Digital presenceAdaltis compliance and trust
Trust signalCompliance4 records
Adaltis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adaltis leadership team
Management profileNumber of profiles
Adaltis subsidiaries and ownership
Company hierarchySubsidiaries1 record
Adaltis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adaltis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adaltis
What does Adaltis do?
Adaltis S.r.l. develops, manufactures, and markets in-vitro diagnostic (IVD) instruments and reagent kits for clinical laboratories, hospitals, blood banks, and research institutions. The portfolio combines Molecular Diagnostics instruments (MDXlab integrated platform, AMPLilab real-time PCR, EXTRAlab NGS Prep, eLAB automated extractor) with MOLgen RT-PCR and syndromic test kits, alongside MicroELISA immunoassay instruments (Personal LAB, NEXgen) paired with EIAgen and CLIAgen reagent lines, Pchem clinical chemistry reagents, Blue Star TMB substrate, OEM services, and consumables/spare parts.
Is Adaltis a public or private company?
Adaltis is a private company. It is classified as unknown and is currently operating.
When was Adaltis founded?
Adaltis was founded in 1987. It employs 11 to 50 people.
Where is Adaltis based?
Adaltis is headquartered in Montecelio, Italy, in the Europe region.
How does Adaltis make money?
Five revenue lines are on record. IVD Instruments Sales are the primary driver. The others are IVD Reagent Kits, accessories, Consumables & Spare Parts, OEM Services and training Services.
Who are Adaltis's main competitors?
Direct peers on record are Bio-Rad Laboratories, DiaSorin, ELITech Group and Meridian Bioscience. Broad incumbents are Roche Diagnostics, Abbott Diagnostics and Hologic. Regional players are A. Menarini Diagnostics and Copan Diagnostics. Quotient Limited is listed as an emerging player.
Does Adaltis have an API?
No public API is recorded for Adaltis.
What industry is Adaltis in?
Adaltis's product category is In-Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.